Increased gene transfer in acute myeloid leukemic cells by an adenovirus vector containing a modified fiber protein

Gene Therapy

Volumn 6, Issue 3, 1999, Pages 314-320

  Gonzalez, R ^a   Vereecque, R ^a   Wickham, T J ^b   Vanrumbeke, M ^a   Kovesdi, I ^b   Bauters, F ^c   Fenaux, P ^a,c   Quesnel, B ^a,c  

^a INSERM   (France)

^b GENVEC INC   (United States)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Adenovirus; AML; Gene therapy; Heparan sulfates

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARAN SULFATE; HEPARIN LYASE; INTERLEUKIN 3; STEM CELL FACTOR; VIRUS VECTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADENOVIRUS; ARTICLE; CLINICAL ARTICLE; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ACUTE DISEASE; ADENOVIRIDAE; BETA-GALACTOSIDASE; CAPSID; CAPSID PROTEINS; CELL LINE; CELLS, CULTURED; GENE THERAPY; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEPARIN; HEPARITIN SULFATE; HUMANS; INTERLEUKIN-3; LEUKEMIA, MYELOID; STEM CELL FACTOR; TRANSFECTION;

EID: 0033026070     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300836     Document Type: Article

References (29)

1. Watanabe T et al. Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectors. Blood 1996; 87: 5032-5039.
2. Neering SJ et al. Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors. Blood 1996; 88: 1147-1155.
3. Seth P et al. Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging. Cancer Res 1996; 56: 1346-1351.
4. Kim M et al. A novel gene therapy strategy for elimination of prostate carcinoma cells from human bone marrow. Hum Gene Ther 1997; 8: 157-170.
5. Clarke MF et al. A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells. Proc Natl Acad Sci USA 1995; 92: 11024-11028.
6. Wroblewski JM et al. Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus. Cancer Gene Ther 1996; 3: 257-264.
7. Wroblewski JM et al. Adenoviral vectors in hematology: purging, stem cell gene transfer, or both (letter). Blood 1997; 89: 4664-4665.
8. Wattel E et al. Differential efficacy of adenoviral mediated gene transfer into cells from hematological cell lines and fresh hematological malignancies. Leukemia 1996; 10: 171-174.
9. Cantwell MJ, Sharma S, Friedmann T, Kipps TJ. Adenovirus vector infection of chronic lymphocytic leukemia B cells. Blood 1996; 88: 4676-4683.
10. Huang MR et al. TH. Efficient adenovirus-mediated gene transduction of normal and leukemic hematopoietic cells. Gene Therapy 1997; 4: 1093-1099.
11. Bergelson JM et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997; 275: 1320-1323.
12. Hong SS et al. Adenovirus type 5 fiber knob binds to MHC class I alpha2 domain at the surface of human epithelial and B lymphoblastoid cells. EMBO J 1997; 16: 2294-2306.
13. Tomko RP, Xu R, Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci USA 1997; 94: 3352-3356.
14. Huang S, Endo RI, Nemerow GR. Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery. J Virol 1995; 69: 2257-2263.
15. Huang S et al. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol 1996; 70: 4502-4508.
16. Dietz AB, Pavlovic SV. High efficiency adenovirus mediated gene transfer to human dendritic cells. Blood 1998; 91: 392-398.
17. Wickham TJ et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol 1997; 71: 8221-8229.
18. Wickham TJ, Roelvink PW, Brough DE, Kovesdi I. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types. Nat Biotechnol 1996; 14: 1570-1573.
19. Wickham TJ et al. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J Virol 1996; 70: 6831-6838.
20. Wickham TJ et al. Targeted adenovirus-mediated gene delivery to T cells via CD3. J Virol 1997; 71: 7663-7669.
21. Wickham TJ, Haskard D, Segal D, Kovesdi I. Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation. Cancer Immunol Immunother 1997; 45: 149-151.
22. Wickham TJ, Carrion ME, Kovesdi I. Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Therapy 1995; 2: 750-756.
23. Krasnykh VN, Mikheeva GV, Douglas JT, Curiel DT. Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism. J Virol 1996; 70: 6839-6846.
24. Stevenson SC, Rollence M, Marshall-Neff J, McClelland A. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J Virol 1997; 71: 4782-4790.
25. + hematopoietic precursor cells with early myeloid and B-lymphoid cell phenotypes. Blood 1993; 82: 2649-2663.
26. Chung CS, Hsiao JC, Chang YS, Chang W. A27L protein mediates Vaccinia virus interaction with cell surface heparan surface. J Virol 1998; 8: 157-170.
27. Dilloo D et al. A novel herpes vector for the high-efficiency transduction of normal and malignant human hematopoietic cells. Blood 1997; 89: 119-127.
28. Shieh MT, Spear PG. Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin. J Virol 1994; 68: 1224-1228.
29. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 1993; 73: 309-319.